Healthcare | January 05, 2023
Viatris acquires Oyster Point Pharma and Famy Life Sciences
Acquisitions have the potential to add at least $1 billion in sales by 2028
Acquisitions have the potential to add at least $1 billion in sales by 2028
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Having a healthy gut is key as it permits the body to build a stronger immune system
Cipla and Ethris partner for the development of mRNA-based therapies
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Company to open new headquarters in 2024
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
Subscribe To Our Newsletter & Stay Updated
